$GILD Recent News 3 top trades for 2014 6:00 a.m. Dec.

New Post Public Reply Private Reply Replies (0) Message Board

Jan 3, 2014 at 12:01 PM

$GILD Recent News

3 top trades for 2014 6:00 a.m. Dec. 30, 2013 - Jeff Reeves
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - blogs.marketwatch.com
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Saumya Vaishampayan
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:18 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - blogs.marketwatch.com
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 12:23 p.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 6:13 p.m. Oct. 29, 2013 - Wallace Witkowski
Gilead profit up 17% as HIV drugs top sales growth 5:06 p.m. Oct. 29, 2013 - MarketWatch.com
Gilead shares rise 1% in late trading 4:58 p.m. Oct. 29, 2013 - Laura Mandaro
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
Healthcare stocks fall from first place in race for year's best-performing sector 3:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
In focus: Overbought conditions abound 8:20 p.m. Oct. 23, 2013 - Lawrence G. McMillan
Best Buy tops S&P 500; Netflix snaps losing streak 4:20 p.m. Oct. 10, 2013 - Saumya Vaishampayan
Best Buy, Gilead Sciences lead S&P 500 gainers 4:05 p.m. Oct. 10, 2013 - Polya Lesova
Gilead, Acura stand out on up day for stocks, Quest tumbles 11:27 a.m. Oct. 10, 2013 - blogs.marketwatch.com
Gilead ends leukemia study after positive results 5:09 p.m. Oct. 9, 2013 - MarketWatch.com
Citrix, Ruby Tuesday shares fall after hours 5:05 p.m. Oct. 9, 2013 - Wallace Witkowski

Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity 10:12 a.m. Today - Seeking Alpha
GILD: Get on While Biotech Remains Hot 5:15 a.m. Today - InvestorPlace.com
Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014 2:27 a.m. Today - Seeking Alpha
Bullish on Gilead - Analyst Blog 12:10 p.m. Jan. 2, 2014 - Zacks.com
Maxim hikes target on Gilead as Sovaldi continues to impress 10:45 a.m. Jan. 2, 2014 - Seeking Alpha
UBS Top High Conviction Stock Picks for 2014 7:46 a.m. Jan. 2, 2014 - 247WallSt.com
The Top Five Drug Launches Of 2013 12:42 p.m. Dec. 31, 2013 - Investors Business Daily
Deutsche still bullish on Gilead after Sovaldi launch 10:36 a.m. Dec. 31, 2013 - Seeking Alpha
Gilead Sciences Inc. (GILD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Dec. 31, 2013 - Zacks.com
Growth Portfolio Super Bowl 2:03 a.m. Dec. 31, 2013 - Seeking Alpha
All 10 Stock Sectors Post Gains in Big Year 10:18 p.m. Dec. 30, 2013 - WSJ.com
Update on RedHill Biopharma's Pipeline - Analyst Blog 6:30 p.m. Dec. 30, 2013 - Zacks.com
Should You Sell Gilead Sciences After A Successful 2013? 1:00 p.m. Dec. 30, 2013 - Seeking Alpha
Weekly CFO Sells Highlight: Facebook Inc., Google Inc., Verisk Analytics Inc., Gilead Sciences Inc. 10:27 a.m. Dec. 30, 2013 - GuruFocus.com
The Best Mutual Funds of 2013 9:13 a.m. Dec. 30, 2013 - InvestorPlace.com
Top Analyst Upgrades and Downgrades: Gilead, Teva, Textura, Twitter and More 8:05 a.m. Dec. 30, 2013 - 247WallSt.com
On the Road to Riches in Biotech 4:10 a.m. Dec. 28, 2013 - Barrons.com
Merck Plans Radical Overhaul of Drug R&D Unit 5:20 p.m. Dec. 27, 2013 - WSJ.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Laggard 5:01 p.m. Dec. 27, 2013 - TheStreet.com
Genomic Health Remains Neutral - Analyst Blog 2:55 p.m. Dec. 27, 2013 - Zacks.com

Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
Health Canada Issues Notice of Compliance for Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 8:30 a.m. Dec. 16, 2013 - BusinessWire
U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera(R) for Patients Switching from a Stable Regimen 4:30 p.m. Dec. 13, 2013 - BusinessWire
HealthStat Rx: Curing Hepatitis C (HCV) With Confidence 10:07 a.m. Dec. 12, 2013 - BusinessWire
Here to Track Insider Trading of Gilead Sciences, Microsoft, Halliburton 8:55 a.m. Dec. 11, 2013 - PR Newswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE
Interest Stock Analysis: Gilead Sciences, Acura Pharmaceuticals, Barnes & Noble, Micron Technology 11:00 a.m. Dec. 9, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent Non-Hodgkin's Lymphoma 6:00 p.m. Dec. 8, 2013 - BusinessWire
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia 6:30 p.m. Dec. 7, 2013 - BusinessWire
U.S. Food and Drug Administration Approves Gilead's Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 4:19 p.m. Dec. 6, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Amidst Market Turmoil

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

Jollibee and DreamWorks Unite for Cultural Celebration

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Austin PostalAnnex Changes Hands After 19 Years

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Spot the Signs: Early Gum Disease Insights from Experts

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Muscle Car Fever Revs Up in New Global TV Series

Chasing the Dream on Wheels Amid the buzz of New York, there's a roar building up that's hard to ignore. It's a sound that echoes through time, capturing the imagination of petrol heads everywhere—those legendary American muscle cars are back in the limelight. I mean, who hasn't dreamt of launching down a highway in a '69 Ford Mustang? 'The Hunt for Rolling Treasure' is...

India's First Upright Proton Therapy System Unveiled

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Drunk Angel Celebrates First Year in Crystal Jewelry

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

BrightPlan's AI-Powered Growth: Series C Fuel

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Mandeville Pests: Health Dangers Lurking at Home

Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...